Drug intelligence / Profile preview

Lactobacillus pentosus

Development stage
Unknown
Lead developer
Korea Food Research Institute
Modality
Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Lactobacillus pentosus (recently reclassified as Lactiplantibacillus pentosus) is a species of probiotic lactic acid bacteria. [1] It is administered orally and is being investigated for its potential to modulate the gut microbiome and host immune system. [1, 8] A clinical study in children with atopic dermatitis (AD) investigated its effects on disease severity. [6, 11] While the study did not show a significant benefit over placebo for the overall group, it did note an improvement in subjective symptoms for a subgroup of children with allergen-sensitized AD. [6, 11] Its proposed mechanism involves restoring immune balance, producing antimicrobial substances, and enhancing the intestinal barrier function. [1, 7, 8] It is also studied for other conditions like gastrointestinal disorders, and for its antimicrobial properties in food preservation. [1, 5, 9]

Other names
Lactiplantibacillus pentosus

Beyond the preview

Go deeper on Lactobacillus pentosus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobacillus pentosus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call